240 related articles for article (PubMed ID: 33594224)
21. Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury.
Laverse E; Guo T; Zimmerman K; Foiani MS; Velani B; Morrow P; Adejuwon A; Bamford R; Underwood N; George J; Brooke D; O'Brien K; Cross MJ; Kemp SPT; Heslegrave AJ; Hardy J; Sharp DJ; Zetterberg H; Morris HR
Brain Commun; 2020; 2(2):fcaa137. PubMed ID: 33543129
[TBL] [Abstract][Full Text] [Related]
22. Leakage of astrocyte-derived extracellular vesicles in stress-induced exhaustion disorder: a cross-sectional study.
Wallensten J; Nager A; Åsberg M; Borg K; Beser A; Wilczek A; Mobarrez F
Sci Rep; 2021 Jan; 11(1):2009. PubMed ID: 33479350
[TBL] [Abstract][Full Text] [Related]
23. Valproic Acid Treatment Decreases Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels in Swine Subjected to Traumatic Brain Injury.
Korley FK; Nikolian VC; Williams AM; Dennahy IS; Weykamp M; Alam HB
J Neurotrauma; 2018 May; 35(10):1185-1191. PubMed ID: 29415612
[TBL] [Abstract][Full Text] [Related]
24. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
[TBL] [Abstract][Full Text] [Related]
25. Chronic immunosuppression across 12 months and high ability of acute and subacute CNS-injury biomarker concentrations to identify individuals with complicated mTBI on acute CT and MRI.
Clarke GJB; Follestad T; Skandsen T; Zetterberg H; Vik A; Blennow K; Olsen A; Håberg AK
J Neuroinflammation; 2024 Apr; 21(1):109. PubMed ID: 38678300
[TBL] [Abstract][Full Text] [Related]
26. Serum assessment of traumatic axonal injury: the correlation of GFAP, t-Tau, UCH-L1, and NfL levels with diffusion tensor imaging metrics and its prognosis utility.
Castaño-Leon AM; Sánchez Carabias C; Hilario A; Ramos A; Navarro-Main B; Paredes I; Munarriz PM; Panero I; Eiriz Fernández C; García-Pérez D; Moreno-Gomez LM; Esteban-Sinovas O; Garcia Posadas G; Gomez PA; Lagares A
J Neurosurg; 2023 Feb; 138(2):454-464. PubMed ID: 35901687
[TBL] [Abstract][Full Text] [Related]
27. Serum GFAP, NfL, and tau concentrations are associated with worse neurobehavioral functioning following mild, moderate, and severe TBI: a cross-sectional multiple-cohort study.
Edwards KA; Lange RT; Lippa SM; Brickell TA; Gill JM; French LM
Front Neurol; 2023; 14():1223960. PubMed ID: 38292036
[TBL] [Abstract][Full Text] [Related]
28. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
[TBL] [Abstract][Full Text] [Related]
29. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
[TBL] [Abstract][Full Text] [Related]
30. Neurofilament light as a biomarker in traumatic brain injury.
Shahim P; Politis A; van der Merwe A; Moore B; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Gill JM; Brody DL; Zetterberg H; Blennow K; Chan L
Neurology; 2020 Aug; 95(6):e610-e622. PubMed ID: 32641538
[TBL] [Abstract][Full Text] [Related]
31. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
[TBL] [Abstract][Full Text] [Related]
32. Traumatic Brain Injury in Children: Glial fibrillary Acidic Protein and Clinical Outcomes.
Ryan E; Kelly L; Stacey C; Duff E; Huggard D; Leonard A; Boran G; McCollum D; Doherty D; Bolger T; Molloy EJ
Pediatr Emerg Care; 2022 Mar; 38(3):e1139-e1142. PubMed ID: 34469402
[TBL] [Abstract][Full Text] [Related]
33. Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction.
Vågberg M; Norgren N; Dring A; Lindqvist T; Birgander R; Zetterberg H; Svenningsson A
PLoS One; 2015; 10(8):e0135886. PubMed ID: 26317831
[TBL] [Abstract][Full Text] [Related]
34. Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.
Wang KK; Yang Z; Yue JK; Zhang Z; Winkler EA; Puccio AM; Diaz-Arrastia R; Lingsma HF; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Manley GT; Cooper SR; Dams-O'Connor K; Hricik AJ; Inoue T; Maas AI; Menon DK; Schnyer DM; Sinha TK; Vassar MJ
J Neurotrauma; 2016 Jul; 33(13):1270-7. PubMed ID: 26560343
[TBL] [Abstract][Full Text] [Related]
35. Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.
Klitholm M; Jeppesen AN; Christensen S; Parkner T; Tybirk L; Kirkegaard H; Sandfeld-Paulsen B; Grejs AM
Resuscitation; 2023 Dec; 193():109983. PubMed ID: 37778613
[TBL] [Abstract][Full Text] [Related]
36. Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.
Lin X; Lu T; Deng H; Liu C; Yang Y; Chen T; Qin Y; Xie X; Xie Z; Liu M; Ouyang M; Li S; Song Y; Zhong N; Qiu W; Zhou C
J Neurol; 2022 Feb; 269(2):815-823. PubMed ID: 34283286
[TBL] [Abstract][Full Text] [Related]
37. Serum NfL and GFAP as biomarkers of progressive neurodegeneration in TBI.
Shahim P; Pham DL; van der Merwe AJ; Moore B; Chou YY; Lippa SM; Kenney K; Diaz-Arrastia R; Chan L
Alzheimers Dement; 2024 May; ():. PubMed ID: 38805359
[TBL] [Abstract][Full Text] [Related]
38. Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study.
Yue JK; Yuh EL; Korley FK; Winkler EA; Sun X; Puffer RC; Deng H; Choy W; Chandra A; Taylor SR; Ferguson AR; Huie JR; Rabinowitz M; Puccio AM; Mukherjee P; Vassar MJ; Wang KKW; Diaz-Arrastia R; Okonkwo DO; Jain S; Manley GT;
Lancet Neurol; 2019 Oct; 18(10):953-961. PubMed ID: 31451409
[TBL] [Abstract][Full Text] [Related]
39. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
Kanberg N; Simrén J; Edén A; Andersson LM; Nilsson S; Ashton NJ; Sundvall PD; Nellgård B; Blennow K; Zetterberg H; Gisslén M
EBioMedicine; 2021 Aug; 70():103512. PubMed ID: 34333238
[TBL] [Abstract][Full Text] [Related]
40. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
